why is there a shortage of glp 1 FDA Ends Compounding GLP-1 Drugs as Shortages Improve, The U.S. Food and Drug Administration (FDA) has announced the end of the for GLP-1 weight loss drugs like Ozempic, leading to the Addressing the Shortage of GLP-1

GPhC registration and UK-based prescribers should be treated as essential, not optional

A plate of baked chicken, soft green beans, and a few bites of sweet potato usually lands better than a giant chopped salad with creamy dressing

Common side effects relating to sitagliptin include: Infections of the upper respiratory tract Headaches More infrequently, Sitagliptin is associated with abdominal pain, nausea and diarrhoea

Ive been on a GLP-1 for about a year now

Clin Chim Acta Int J Clin Chem (2001) 314:4753

Because of this issue, it is important to strongly consider the psychosocial health of children when also considering initiating them on GLP-1 medications